cGxP.wire https://validator.w3.org/feed/docs/rss2.html RenovoRx Highlights TAMP Targeted Drug Delivery Data Mend Expands Mend Well Into Chronic Care Management HCW Biologics Advances TGF-β/IL-15 Cancer Immunotherapy Alkermes Publishes Alixorexton Phase 2 Narcolepsy Data Vascarta Advances VAS-101 as Non-Opioid Pain Therapy Savara Highlights Molgramostim Phase 3 Data at ERS 2026 Revier Therapeutics Launches with €6M Cardiometabolic Funding Celea Therapeutics Advances Phase 3 Deupirfenidone Program in IPF Summit Advances Ivonescimab in Global HARMONi Trial Sagimet Advances Denifanstat Acne Phase 3 Trial Apollo Therapeutics Reports Positive APL-10456 Phase 1 Data BioCryst Wins Japan Approval for Pediatric ORLADEYO Basking Biosciences Reports Positive Phase 1 Data for BB-025 Senhwa Completes CX-5461 Phase 1b Trial Enrollment Cambrex High Point Completes Global FDA Pre-Approval Inspections Lakefront Biotherapeutics Gains FDA Orphan Status for Gamgertamig Leads Biolabs Advances Opamtistomig Phase II ESCC Study Rhythm Pharmaceuticals Wins Japan Approval for IMCIVREE Caristo Diagnostics to Highlight AI Stroke Prediction at ESC 2026 Hanmi Pharm Licenses Obesity Drug HM17321 to Genentech PTC Therapeutics Highlights Sephience PKU Data at SSIEM 2026 Eisai and Biogen Launch LEQEMBI IQLIK for Alzheimer’s Johnson & Johnson Launches Global DISH Surgical Outcomes System Anixa Biosciences Advances Breast Cancer Vaccine and CAR-T Programs Astellas Starts Phase 3 Trial of ASP2138 in Gastric Cancer Antengene Wins Australian Trial Approval for ATG-201 Vanda Pharmaceuticals Gains EU Orphan Status for Imsidolimab Quest Diagnostics Adds Roche pTau217 Blood Test to AD Portfolio Johnson & Johnson Wins FDA Approval for IMAAVY in wAIHA Akeso Advances AK157D1 B7-H3 ADC Into Phase I Antengene Reports First Profit as Pipeline Advances Henlius Reports 2026 Interim Results, Global Growth Advances Evolved By Nature Peptide Platform Advances Atopic Dermatitis Care ASHP and APhA Call for Stronger Medication Safety Allies of Skin Launches Peptint Tripeptide Lip Treatment AbbVie Highlights Lung Cancer Pipeline Data at WCLC 2026 PharmAla Advances MDXX Manufacturing and Drug Pipeline Implantica Wins FDA Approval for RefluxStop® in U.S. C2N PrecivityAD2 FDA Clearance Advances Alzheimer’s Testing Milestone Starts Phase 3 Trial for AFib-RVR Therapy Werewolf Therapeutics and Ambros Announce $150M Merger Alvotech Expands Biosimilar Reach With Lotus Partnership SK pharmteco Showcases Global CDMO Manufacturing at CPHI Johnson & Johnson Expands TECVAYLI for Multiple Myeloma Care Dizal to Present ZEGFROVY NSCLC Data at WCLC 2026 Leads Biolabs Advances Opamtistomig Toward Approval Orum Therapeutics Gains FDA Clearance for ORM-1153 Chai Discovery and BMS Advance AI Antibody Discovery Raintree Expands Agentic AI for Rehab Therapy Protagenic Advances PT00114 Toward FDA IND Submission